Dr. Oh on Results of Chemotherapy Versus ARTA in Prostate Cancer
February 17th 2017William Oh, MD, professor, Mount Sinai Hospital, discusses the results from a trial that compared second-line chemotherapy to alternative androgen receptor-targeted agents (ARTA) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Read More